Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2022 Apr 4;18(4):e1010145. doi: 10.1371/journal.pgen.1010145

The spindle assembly checkpoint and the spatial activation of Polo kinase determine the duration of cell division and prevent tumor formation

Emmanuel Gallaud 1, Laurent Richard-Parpaillon 1, Laetitia Bataillé 1, Aude Pascal 1, Mathieu Métivier 1, Vincent Archambault 2, Régis Giet 1,*
Editor: Yan Song3
PMCID: PMC9009772  PMID: 35377889

Abstract

The maintenance of a restricted pool of asymmetrically dividing stem cells is essential for tissue homeostasis. This process requires the control of mitotic progression that ensures the accurate chromosome segregation. In addition, this event is coupled to the asymmetric distribution of cell fate determinants in order to prevent stem cell amplification. How this coupling is regulated remains poorly described. Here, using asymmetrically dividing Drosophila neural stem cells (NSCs), we show that Polo kinase activity levels determine timely Cyclin B degradation and mitotic progression independent of the spindle assembly checkpoint (SAC). This event is mediated by the direct phosphorylation of Polo kinase by Aurora A at spindle poles and Aurora B kinases at centromeres. Furthermore, we show that Aurora A-dependent activation of Polo is the major event that promotes NSC polarization and together with the SAC prevents brain tumor growth. Altogether, our results show that an Aurora/Polo kinase module couples NSC mitotic progression and polarization for tissue homeostasis.

Author summary

Stem cells divide asymmetrically and exist in limited numbers in tissues to ensure their development and repair. To do so, stem cells are subjected to a rigorous progression of mitotic events to avoid chromosome segregation errors during cell division, and formation of aneuploid daughter cells with impaired proliferative capacities. Moreover, during mitosis, these stem cells are characterized by their polarization along an apical-basal axis. The orientation of the mitotic spindle along this axis allows the asymmetric distribution of cell fate determinants after cell division. This differential segregation is required to contain stem cell amplification and tumor formation. How mitotic progression is coupled to cell polarization at the molecular level during stem cell asymmetric division is therefore a critical question. We show here that the levels of active Polo kinase regulate the duration of cell division. Polo activation is regulated via a direct activating phosphorylation by Aurora A and Aurora B kinases. Moreover, activation of Polo kinase by Aurora A is essential to maintain polarization of mitotic stem cells and consequently to prevent tumor formation. Altogether, our results strongly suggest that an Aurora-dependent phosphorylation cascade leading to the activation of Polo kinase regulates the coupling between mitotic progression and tissue homeostasis.

Introduction

The maintenance of a restricted number of stem cells is essential for tissue homeostasis and repair [1]. This process has been particularly well described during Drosophila brain development; loss of NSCs causes microcephaly while their amplification triggers tissue overgrowth [26]. NSCs are subjected to asymmetric cell division. This event is characterized by the asymmetric localization of PAR proteins at the apical cortex that triggers cell fate determinants targeting at the basal cortex. After mitotic spindle alignment along the apico-basal axis, NSC asymmetric cell division gives rise to one cell retaining the NSC proliferation fate while the other cell (GMC for Ganglion Mother Cell) inherits cell fate determinants and is subjected to differentiation (reviewed in [7]). Both AurA and Polo are needed for cell polarization and for mitotic spindle alignment [811]. As a consequence, in aurA and polo mutants, the two daughter cells acquire the NSC proliferative fate, resulting in the amplification of the NSC population and tumor formation in neural tissues. Therefore, in the context of central brain development, aurA and polo genes are both tumor suppressors [2,9,10,12].

Another remarkable feature of aurA mutant neural tissue is the absence of obvious chromosome segregations defects despite severe impairment of mitotic spindle assembly [2]. Correct chromosome segregation in many cell types depends on the Spindle Assembly Checkpoint (SAC) that delays mitotic progression and anaphase onset until all kinetochores are properly attached to spindle microtubules (reviewed in [13]). As a consequence, ablation of SAC genes in dividing cancer cells induces premature anaphase onset and chromosome segregation defects, cell death or premature differentiation [2,3,1417]. aurA mutant NSCs show defective mitotic spindle assembly and Cyclin B-Cdk1 levels persist longer than normal, consistent with SAC-dependent mitotic delay [2,18,19]. However, SAC ablation in aurA mutant does not restore normal mitotic progression, indicating that AurA regulates mitotic progression independently from the SAC [2]. Altogether, these studies suggest that tissue homeostasis is regulated by AurA kinase that couples mitotic progression to accurate asymmetric cell division of NSCs. The possible AurA targets required for these processes remains elusive. Polo-like kinases 1 were shown, in some cases, to be activated by Aurora kinases in cellulo [2025]. Polo was therefore a potential candidate to function downstream of Aurora A in NSCs. In this study we analyzed asymmetric cell division and mitotic progression in polo, aurA and aurB/ial mutants using gain and loss-of function alleles. In the context of the stem-cell based Drosophila central brain development, we show here that asymmetric cell division is coupled to mitotic progression and mainly regulated by the direct activation of Polo kinase by Aurora A and Aurora B in vivo.

Result

polo mutants NSCs exhibit a SAC-independent mitotic delay caused by defective Cyclin B degradation

We first wished to determine if Polo activity promotes mitotic progression in NSCs. To avoid delay caused by possible SAC activation, we examined how time in mitosis was regulated in different polo mutants associated with a loss of the SAC gene Mad2 (polo,mad2P). Western blotting analyses of brain tissues confirmed the absence of Mad2 in the double mutants and the lower or absent Polo protein levels in weak and strong hypomorphs respectively (Fig 1A). Using live-imaging microscopy, we found that the weak polo1/polo10 and polo1/polo9 hypomorphic mutants showed a prolonged mitosis that was not decreased by absence of the SAC (Fig 1B and 1C). The time in mitosis was even more prolonged in strong hypomorphic polo9/polo10 mutants but by contrast to weak polo hypomorphs, ablation of the SAC decreased the time in mitosis. It indicates a partial SAC contribution to mitotic delay in strong hypomorphic polo mutants. This trends were confirmed by analyses of the delay between SAC silencing (as detected by the loss of GFP::Mad2 at kinetochores) and anaphase onset in weak and strong polo mutants (Fig 1D and 1E). As a positive control, NSCs were treated by colchicine to activate the SAC. Under these conditions, GFP::Mad2 signal on the kinetochores persisted during all the duration of the experiment, confirming that the SAC was functional in NSCs [26]. The time between SAC silencing and anaphase onset was 0.8 min in controls, 2.1 to 2.4 min in polo1/polo10 and polo1/polo9 and 8.6 min in polo9/polo10 NSCs. This result reveals that weak interference with Polo kinase prolonged mitosis mostly in a SAC-independent manner while mitotic delay is partly SAC-dependent in strong polo hypomorphs. Altogether, these results indicate that the SAC cannot account for the prolonged mitosis of weak and strong polo hypomorphic mutant NSCs. In a previous study, we showed that a similar SAC-independent mitotic delay was caused by a failure to timely degrade Cyclin B in aurA mutants [2]. We therefore analyzed Cyclin B degradation in strong hypomorphic polo mutants lacking a functional SAC by adding the mad2P null mutation [26]. We found that the mitotic delay of polo mutants was accompanied by an impaired Cyclin B degradation (S1 Fig). These phenotypes were partly rescued by abrogation of the SAC. Therefore, aurA and polo mutant NSCs both show a SAC-independent Cyclin B degradation causing a mitotic delay.

Fig 1. polo mutant NSCs display a SAC-independent mitotic delay.

Fig 1

A) Polo, Mad2 and Actin Western blot analyses in polo and polo,mad2P mutant brain extracts. The genotypes are indicated for each lane. polo1/polo10 and polo1/polo9 are weak hypomorphs and polo9/polo10 is a strong hypomorph. B) Time-lapse imaging of mitosis in polo mutants in the absence or presence of Mad2. Selected image series of dividing NSCs of the indicated genotypes expressing mCherry::Tubulin. The white dashed line outlines the dividing NSCs. Scale bar: 5 μm. Time is min:s (t = 00:00 is NEBD). C) Quantification of time in mitosis from NEBD to anaphase onset for NSCs of the indicated genotypes. Means are shown as black bars. Mann-Whitney unpaired test: ns: p>0.05; *: p<0.05; ****: p<0.0001. D) GFP::Mad2 kinetochore localization in control, colchicine-treated, and polo mutant NSCs expressing H2A::RFP. Colchicine treatment (20μM) was used as a control for GFP::Mad2 accumulation on kinetochores. Yellow arrowheads indicate the last kinetochore labeled with GFP::Mad2 before anaphase onset (AO). Scale bar: 5 μm. Time is min:s (t = 00:00 is the beginning of the experiment). E) Quantification of the time between SAC satisfaction (disappearance of the last GFP::Mad2-labeled kinetochores) and anaphase onset in NSCs of the indicated genotypes. Means are shown as black bars. Mann-Whitney unpaired test: ****: p<0.0001. Numerical data (mean, SD and n) related to all the figures are available in S1 Data.

Thresholds of Polo activation control mitotic progression

In human cultured cells and Xenopus, the activation of the Polo orthologue Plk1 was shown to be triggered by the phosphorylation of the conserved Thr210 residue and Plk1 activity is sensitive to Aurora A inhibitors [24,25,27,28]. Therefore, we wondered if an Aurora A-mediated activation of Polo kinase could also regulate mitotic progression in NSCs. We hypothesized that the expression of a constitutively active Polo kinase (PoloT182D in flies) should rescue the longer time in mitosis of aurA mutants NSCs. In order to test this idea, we generated new transgenic flies allowing the expression of different GFP-tagged variants of Polo kinase in brain tissues including wild type (PoloWT), kinase-dead (PoloK54M), constitutively active (PoloT182D) and constitutively inactive (PoloT182A). Live-imaging experiments on intact brains confirmed that each variant displayed a particular localization on centrosomes, mitotic spindle, midbody and kinetochores of NSCs, similar to what was previously reported in early embryos and S2 cells (S2 Fig and S1 Movie) and [29]. Moreover, only PoloWT::GFP was able to restore viability of the strong polo9/10 hypomorph (hereafter referred to as polo mutant) when expressed under the control of a ubiquitous Actin5C promoter (Fig 2A and 2B). We then assayed the ability of each of these variants to reduce the time in mitosis of polo mutant NSCs by live-imaging microscopy (Fig 2C and 2D). Expression of PoloT182D, PoloT182A and PoloK54M in a WT background slightly increased the time in mitosis of NSCs when compared to the expression of PoloWT, suggesting hypermorphic or dominant-negative effects because these kinases variants harbor the Polo boxes that can displace endogenous Polo kinase [30]. Expression of PoloWT was able to restore a normal time in mitosis when expressed in polo mutants. Expression of the PoloT182D variant restored by more than half mitotic duration of polo mutant NSCs. By contrast, expression of the inactive PoloT182A or the PoloK54M variants did not. It indicates that Polo kinase activity and more specifically activating phosphorylation on T182, is required for normal mitotic progression.

Fig 2. Constitutive Polo kinase activity is not compatible with normal mitosis duration and Drosophila viability.

Fig 2

A) Polo and Actin Western blot analyses showing the expression of endogenous Polo kinase in control and GFP-tagged Polo variants (WT, T182D, T182A and K54M) expressed ubiquitously in polo mutant brains. The genotypes are indicated for each lane. Actin was used as a loading control. B) Hatching rates of polo mutants expressing the indicated Polo variants. C) Time-lapse imaging of mitosis in polo mutant NSCs expressing the indicated Polo variants and mCherry::Tubulin. The white dashed lines outline the dividing NSCs. Scale bar: 5 μm. Time is min:s (t = 00:00 is NEBD). D-E) Quantification of the time in mitosis of NSCs of the indicated genotypes. Means are shown as black bars. Mann-Whitney unpaired test: ns: p>0.05; *: p<0.05; ****: p<0.0001.

We envisaged that the expression of a constitutively active PoloT182D variant may be detrimental for spindle assembly and trigger a SAC-dependent mitotic delay, as shown in previous studies [3134]. We challenged this hypothesis by measuring the time in mitosis of NSCs upon PoloT182D expression in mad2P and polo,mad2P double mutant (Fig 2E). The moderate increased time in mitosis resulting from PoloT182D expression in WT cells was not abrogated following deletion of the SAC, indicating that this delay did not result from SAC activation but by constitutive Polo kinase activity. Congruently, expression of PoloT182D was unable to fully restore the time in mitosis of polo,mad2P double mutant NSCs. Altogether, this reveals that a fine-tuning of Polo activity thresholds is crucial to fulfill normal mitotic progression in a SAC-independent manner.

Centrosomal AurA and centromeric Ial/AurB kinases are both required for Polo-dependent mitotic progression

We wanted to investigate if the mitotic progression defect observed in aurA and in aurA,mad2P mutants shown in our previous study was Polo-kinase-dependent [2]. Thus, we expressed PoloWT, PoloT182A and PoloT182D in these backgrounds (Figs 3A, 3B, S3A and S2 Movie). We found that expression of PoloT182D was able to reduce the time in mitosis of both aurA and aurA,mad2P mutants NSCs, suggesting that Polo kinase T182 phosphorylation by Aurora A contributes to mitotic progression. In addition, a study has shown that the mitotic phosphorylation of Polo on T182 is also mediated by Aurora B kinase, a component of the Chromosome Passenger Complex (CPC), at centromeres and during cytokinesis [23,29,35]. We therefore wondered if the fly orthologue of Aurora B, known as Ial (Ipl1-Aurora-like), was also contributing, with Aurora A, to the control of the time in mitosis through Polo kinase phosphorylation on T182. As described before for CPC mutants, NSCs from ial hypomorphic mutant displayed moderate prolonged mitosis (9.2 min for ial2A43/ial1689 vs 6.0 min in a control, Figs 3C, 3D, and S3C and [36]). This delay was significantly reduced upon PoloT182D but not by PoloT182A expression indicating that the mitotic delay in ial mutant is partially dependent upon T182 phosphorylation. We found that combination of ial and aurA mutations triggered a synergistic delay in the time in mitosis, as most of the double mutant NSCs failed to exit mitosis after 150 min (S3B and S3C Fig). Expression of an active PoloT182D did not recue the mitotic arrest observed in these double aurA,ial mutant background (S3C Fig).

Fig 3. Mitotic delays in aurA and aurB mutants are Polo-dependent.

Fig 3

A, C) Time-lapse imaging of mitosis in aurA (A) and aurB/ial (B) mutant NSCs expressing the indicated Polo variants and mCherry::Tubulin. The white dashed lines outline the dividing NSCs. Scale bar: 5 μm. Time is min:s (t = 00:00 is NEBD). B, D) Quantification of time in mitosis for the indicated genotypes. Means are shown as black bars. Mann-Whitney unpaired tests: ns: p>0.05; *: p<0.05; **: p<0.01; ****: p<0.0001.

Polo kinase activity is spatially regulated at the spindle poles and the centromeres by Aurora A and Aurora B respectively ([27,37] for review and [35]). To investigate loss of Aurora kinase activities with spatial activation of Polo, we first monitored the levels of T182 phosphorylation at the centromeres. We found that centromeric Ph-T182 Polo levels were high in control and aurA metaphase NSCs, and lowered in polo and ial mutants. We also found that ial;aurA double mutants NSCs that were arrested in mitosis displayed nearly normal levels of centromeric Ph-T182 Polo, ruling out that centromeric active Polo is the main contributor that controls mitotic progression (S3D and S3E Fig). Because the anti- Ph-T182 Polo antibody did not label Drosophila mitotic centrosomes, we examined the levels of Centrosomin (Cnn) that oligomerizes and is recruited at centrosomes following direct phosphorylation by Polo kinase [38]. Compared to control metaphase NSCs, the levels of centrosomal Cnn were strongly reduced in aurA mutant. Centrosomal level of Cnn remained low in aurA mutant NBs expressing additional PoloWT::GFP or the PoloT182A variant (S4 Fig). However, PoloT182D expression in mitotic aurA cells was able to significantly rescue the amount of centrosomal Cnn, although these levels were very low (only 10%) compared to those observed in control metaphase NBs. (S4A and S4B Fig). Altogether, these results strongly suggest that both Aurora A and Ial phosphorylates Polo on T182 to regulate mitotic progression of NSCs in vivo.

Polo and the SAC protect NSCs against aneuploidy and excessive proliferation

Normal brain lobes are characterized by a restricted number of ~100 NSCs (reviewed in [7]). Defects in cell polarization or spindle orientation trigger the acquisition of a proliferating fate, the amplification of the NSC pool and ultimately tumor formation [39]. Because AurA and Polo are both required for cell polarization and mitotic spindle alignment in NSCs, aurA and polo mutant brains exhibit higher number of proliferating NSCs and induce tumors when injected in host flies [2,9,12,39,40]. To investigate if polo mutant-derived tumors share similar characteristics with aurA mutant, we undertook a careful analysis of the larval brain tumors derived from polo mutants. We found that NSC numbers increased in the central brain of weak polo mutants and ablation of the SAC with the mad2P mutation enhanced this amplification (Fig 4A and 4B). As abnormal NSCs expansion is notoriously abrogated by aneuploidy in flies [2,3], we monitored the aneuploidy and polyploidy levels of weak polo hypomorphs associated with loss of the SAC (Fig 4C and 4D). We found that aneuploidy and polyploidy level, between 3 and 5% in weak polo hypomorphs, was largely increased upon ablation of the SAC (39 to 41%). It indicates that polo mutants are prone to segregation errors that are enhanced by loss of the SAC. Altogether, our data show that weak polo,mad2P double mutants accumulate chromosome segregation and ploidy defects but exhibit higher NSC amplification. To check if these defects were correlated with changes in tissue proliferation, we performed brain transplantation experiments. We transplanted weak polo mutant brain tissues in which the SAC was active or not, in the abdomen of host WT flies and monitored the growth of the transplants as described before [39,41]. Strikingly, inactivation of the SAC and the subsequent increase in aneuploidy correlated with severely enhanced tumor growth of weaker polo mutant NSCs (45.1 and 51.5% vs. 22.0 and 24.7% of transplanted flies) (Fig 4E and 4F). SAC inactivation in a strong polo hypomorph background did not strongly impair NSC number (Fig 4A and 4B) nor tumor growth (85.2 vs. 86.5% of transplanted flies) (Fig 4E and 4F). These observations are similar to what was described with aurA mutant tumors [2]. Altogether our data suggest that Polo collaborates with the SAC to protect NSCs against chromosome segregation errors. Moreover, these results also reveal for the first time a case in which tumor growth is stimulated by aneuploidy in fly NSCs.

Fig 4. Impairing the SAC in polo mutants induces aneuploidy and promotes tumor growth.

Fig 4

A) Representative images of larval brain lobes of the indicated genotypes stained for the NSC marker Deadpan. The white dashed lines outline the central brain area where NSCs were scored. Note the reduced brain lobe size in the polo9/10 mutant. Scale bar: 100 μm. B) Quantifications of Deadpan-positive NSCs per brain lobe for the indicated genotypes. Mann-Whitney unpaired test: *: p<0.05; ****: p<0.0001. Means are shown in black. C) Representative images of the three classes of mitotic figures observed from squashed brains stained with DAPI: euploid (8 chromosomes), aneuploid (more or less than 8 chromosomes) and polyploid (multiple of 8 chromosomes) cells. Scale bar: 10 μm. D) Percentage of mitotic brain cells with ploidy defects (aneuploidy and polyploidy) for the indicated genotypes. For statistical analyses, the proportion of euploidy was compared to the proportion of ploidy defects. Fisher’s exact test: ns: p>0.05; *: p<0.05; ****: p<0.0001. E) Examples of wild-type adult host flies 15 days after transplantation with control and polo mutant brain lobe expressing H2A::GFP as a readout for tumor development (bottom). Asterisks indicate transplantation scars. F) Proportion of host flies developing tumors following the transplantation of brain lobes from the indicated genotypes. Fisher’s exact test; ns: p>0.05; *: p<0.05; ***: p<0.001.

AurA-dependent tumor suppression is mediated by Polo

Polo and AurA both are involved in mitotic progression and act like tumor suppressors in NSCs. Moreover, we noticed that cell size asymmetry resulting from the division of aurA mutant NSCs appeared to be rescued by PoloT182D expression (last time point in Fig 3A). Therefore, we decided to investigate if the tumor suppression potential of aurA mutants was also Polo-dependent. Consistent with several studies, the NSC number in aurA mutants was increased 10 to 25 times compared to control brains (1970 NSCs per lobe, Fig 5A and 5B) [2,9]. Expression of a PoloWT or the inactive PoloT182A variant did not inhibit NSC amplification. However expression of the active PoloT182D was sufficient to strongly diminish the NSC amplification incurred in aurA mutant tissues (411 NSCs).

Fig 5. Activation of Polo restores NSCs polarization, spindle orientation and inhibits tumor growth in an aurA mutant.

Fig 5

A) Representative images of fixed control and aurA mutant larval brain lobes with or without PoloT182D::GFP expression and stained for the NSC marker Deadpan. The white dashed lines outline the central brain area where NSCs were scored. Note that the expression PoloT182D in aurA mutant restores the delimitation between the central brain and neuroepithelium. Scale bar: 100 μm. B) Quantification of the NSC number in each brain lobe for the indicated genotypes. C) Examples of wild-type adult host flies 15 and 30 days after transplantation with aurA mutant or aurA mutant expressing PoloT182D::GFP brain lobes expressing mCherry::Tubulin as a readout to follow tumor development. Red asterisks indicate transplantation scars. D) Percentage of host flies developing tumors 15 and 30 days after the transplantation of brain lobes from the indicated genotypes. E) Quantification of ploidy defects scored in neural tissue for the indicated genotypes. The proportion of euploidy was compared to the proportion of ploidy defects for statistical analyses. F) Representative images of control, PoloT182D::GFP, aurA mutant and PoloT182D::GFP;aurA metaphase NSCs stained for Miranda (magenta in the merge), aPKC and Phospho-Histone H3 (green in the merge), and α-Tubulin (white in the merge). Yellow arrowheads indicate the edges of aPKC crescent. Scale bar: 5 μm. G) Schematic representation of aPKC localization patterns observed in NSCs: left: aPKC forms a crescent which defines the apical cortex of the control cell; right: aPKC is unpolarized and exhibits a homogenous cytoplasmic and cortical localization. H) Percentage of NSCs of the indicated genotypes with either a polarized apical crescent (light grey) or homogenous cortical and cytoplasmic aPKC localization (dark grey). I) Schematic illustration of the method used to measure the spindle alignment α angle (orange) between the polarity axis (black dashed line), determined by aPKC (green) and Miranda (magenta), and the spindle axis (blue dashed line) determined by spindle poles (See Material and Methods). J) Quantification of the α angle between polarity and spindle axes in metaphase NSCs for the indicated genotypes. Mann-Whitney unpaired test: ns: p>0.05; ****: p<0.0001. Means are shown as black bars. For panels D), E) and H): Fisher’s exact test: ns: p>0.05; *: p<0.05, ***: p<0.001; ****: p<0.0001.

We also compared tumor growth progression after transplantation of aurA mutant neural tissues expressing or not PoloT182D (Fig 5C and 5D). We found that 90% of transplanted aurA mutant brain tissues labeled with mCherry produced large tumors that killed host flies shortly after 15 days. Expression of a PoloWT variant did not compromise the aurA-dependent strong tumor growth. However, when PoloT182D was expressed in aurA mutant, only 10% and 55% of the injected hosts developed tumors after 15 and 30 days respectively (Fig 5D). Importantly, the ploidy defects caused by aurA mutation (11.8% of the cells) were unchanged following PoloT182D expression (13.1% of the cells), ruling out differences in ploidy as the cause of the aurA mutant tumor growth restriction by PoloT182D (Fig 5E).

At the cellular level, Aurora A is required to regulate larval brain NSC number and growth by controlling mitotic spindle orientation and cell polarization, two characteristics of NSC asymmetric division [8,9,11,12,42]. We therefore analyzed these two processes in aurA mutant NSCs expressing PoloT182D. We first monitored NSC polarization by analyzing the localization of aPKC and Miranda apical and basal crescents respectively. We found that both aPKC and Miranda crescents were properly localized in 100% of control or PoloT182D expressing NSCs. By contrast and in agreement with previous reports [9,42], most aurA mutant NSCs (78%) displayed homogenous cortical aPKC while Miranda was properly localized at the basal cortex (Fig 5F and 5H). Strikingly, expression of PoloT182D in aurA mutant restored the presence of the aPKC apical crescent in 84% of the NSCs but not expression of PoloWT or the PoloT182A variants. In parallel, we also measured mitotic spindle alignment along the apico-basal axis in aurA mutant with or without PoloT182D expression. In control and PoloT182D expressing NSCs, the vast majority of mitotic spindles were properly oriented in metaphase (angle < 30°: 95% and 100%) while aurA mutant NSCs displayed a random mitotic spindle alignment (angle < 30°: 41.3%). We found that PoloT182D, expression was sufficient to significantly restore the aurA mutant-dependent spindle alignment defects (angle < 30°: 76.3%; Fig 5F, 5I and 5J) while neither expression PoloWT or PoloT182A were able to rescue this defect. Altogether, these results indicate that Polo functions downstream of AurA to ensure the asymmetry of NSC divisions to prevent their excessive proliferation during larval brain development.

Discussion

Tissue homeostasis in the fly larval brain requires timely mitotic progression for accurate chromosome segregation. Indeed, chromosome segregation defects trigger the formation aneuploid NSCs that fail to proliferate [2,3,17]. Mitotic state is regulated by the maintenance of Cyclin B-CDK1 activity and is under the control of the SAC and a functional APC/C. In a previous study, we showed that Aurora A kinase was also required for timed and efficient Cyclin B degradation in a SAC-independent manner [2]. We now bring in this new study details on the molecular mechanism involved: an Aurora-Polo signaling cascade is pivotal to control cell division length. Similar to aurA, polo mutants NCSs are characterized by a defective Cyclin B degradation. The loss of Aurora A or Ial/Aurora B leads to an extension of the time in mitosis. This mitotic delay can be rescued by the expression of a constitutively active PoloT182D, consistent with the idea that an Aurora-dependent phosphorylation and activation of Polo at T182 is the underlying connection. Our results suggest that although Ial contributes to mitotic progression, the pool of Polo phosphorylated by Ial does not appear to strongly regulate the time in mitosis because normal levels of centromeric Ph-T182 Polo are found in aurA mutant and in ial;aurA double mutant (S3D and S3E Fig). By contrast, mitotic progression is partly rescued in aurA mutant following expression of PoloT182D (Figs 3A, 3B and S3). In these conditions, we observed a weak restoration of Cnn recruitment on the centrosomes (as a readout of Polo activity at spindle poles). Altogether, our results favor a model in which centrosomal Aurora A phosphorylates Polo to produce enough active levels of kinase to support timely Cyclin B degradation and consequently cell division length.

Finally, although we have shown that Polo functions downstream of Aurora family kinases to regulate mitosis timing, an aurA;ial double mutant remains blocked in metaphase in the presence of the active PoloT182D mutant. It is therefore likely that other Aurora-dependent phosphorylation events are required to control Cyclin B degradation (See model in Fig 6). The use of weak or strong hypomorphic polo mutants and the controlled expression of a dominant PoloT182D active kinase allowed to establish the importance of Polo kinase activity thresholds for mitotic progression. Indeed, weak polo hypomorphs are characterized by near normal spindle formation and a prolonged mitosis (~13 min) in which the SAC has no contribution. Strong polo hypomorphs exhibit a longer mitotic delay (~47 min) that is also partly SAC-independent (Figs 1B, 1C, and S1). A past study showed that overexpression of an active Polo T182D triggers defective kinetochore attachments to spindle MTs [31]. The use of the same variant PoloT182D allowed highlighting another subversive function of Polo kinase in the control of cell division length. This reveals that Polo thresholds of activation are essential for timely Cyclin B degradation and mitotic exit in vivo. Our observations could therefore explain the apparent antagonism of the literature: Polo inhibits the APC/C activator Cdc20 when the SAC is unsatisfied but is also necessary to phosphorylate and activate APC/C to trigger mitotic exit [4345].

Fig 6. Model showing Aurora(s)-dependent activation of Polo kinase for mitotic progression and tumor suppression in NSCs.

Fig 6

In fly NSCs, centrosomal/spindle pole-associated Aurora A kinase phosphorylates the Polo activating T182 of to generate active Polo kinase. This event is essential to regulate PAR complex polarized localization/activation and avoid tumor suppression. This activation is possible without centrosomes. To promote timely Cyclin B degradation and mitotic progression, Polo activation requires T182 phosphorylation by both spindle pole-Aurora A and centromeric Ial/Aurora B. This event occurs in parallel of the Spindle assembly checkpoint. Downstream Aurora A and Ial/Aurora B uncharacterized targets participate to this process.

Tissue homeostasis depends on the asymmetric distribution of cell fate determinants during NSC division that prevents their excessive proliferation. This process is regulated by tumor suppressor genes [4,5,7,46]. Polo and Aurora A protein kinases are both required for cell polarization in the one-cell C. elegans embryos and in Drosophila NSCs [9,12,42,4750]. However, this work demonstrates a direct molecular and functional link between these two kinases in the context of organogenesis and tumor suppression. Our study shows that Polo phosphorylation on T182 by Aurora A governs polarization of neural stem cells but also mitotic spindle orientation, two processes that are essential for appropriate cell fate acquisition during asymmetric cell division. Whether this activation is locally and solely regulated at the centrosome remain unclear. Indeed, centrosomes appear to remain poorly functional in aurA mutant NBs expressing the active PoloT182D variant. Furthermore, sas-4 mutants NSCs lacking centrosomes appear to display normal cortical polarity [51]. We therefore favor the hypothesis that providing enough overall active Polo kinase levels may be sufficient to polarize NSCs. The local centrosome activation at spindle poles may not be an absolute requirement for this process. In agreement with this hypothesis, mutation in the Aurora A activator Bora, triggers polarity defects but Bora is cytoplasmic during cell division, and does not show centrosomal or spindle pole localization [20,52,53].

A past study has proposed that direct phosphorylation of the PAR complex by Aurora A contributes to cell polarization [11]. We show here that the amplification of NSCs and the tumor growth of aurA mutant brains are strongly inhibited by the expression of an active Polo variant. This restoration of tissue homeostasis is caused by the near complete rescue of cell polarity defects. We therefore suggest that Polo kinase phosphorylation of yet unidentified substrate(s) mediate polarization of fly NSCs. PAR3 is regulated by direct PLK-1 phosphorylation in the C.elegans embryo although the effects on embryonic polarization are unclear [49]. Further studies will be required to investigate if this direct regulation event is also conserved in fly NSCs. Our results also suggest that Aurora A phosphorylation of the PAR complex may only play a minor role for Aurora A-dependent tumor suppression.

Rescue of spindle orientation in aurA mutant by expression of the active PoloT182D may also be mediated by a direct regulation of the spindle orientation machinery by Polo. However, spindle orientation may also be indirect and stimulated by the weak centrosomal maturation (S4 Fig), triggering microtubule nucleation and interactions with the cell cortex [22,37,38]. In conclusion, this work has revealed that two essential characteristics of NSCs, the progression of mitosis mediated by efficient Cyclin B degradation and cell polarization, are coupled by a signaling cascade leading to the activation of the Polo protein kinase by Aurora kinases. This Aurora/Polo module is critical for tissue homeostasis and when impaired, triggers NSC amplification and tumor development. It is also important to emphasize that our study has shown that neural tumors from polo mutants seem to have specific characteristics: their progression is aggravated by aneuploidy. Further studies will be required to identify and investigate the functions of the Polo targets in these essential processes and how they are regulated in space and time.

Materials and methods

Fly strains and alleles combinations

The following strains were used for this study:

UAS-mCherry::Tubulin (BDSC #25774), Ubi-RFP::Tubulin (gift from Renata Basto), UASt-mCherry::Jupiter (gift from Clemens Cabernard), UAS, His2Av::mRFP1 (H2A::RFP, BDSC #23651), His2Av::GFP (H2A::GFP) [54] and GFP::Mad2 [26] were used to monitor by live-imaging the microtubule network, chromosomes and unattached kinetochores. Wild-type (UASp-PoloWT::GFP), phosphomutant (UASp-PoloT182A::GFP), phosphomimic (UASp-PoloT182D::GFP) and kinase-dead (UASp-PoloK54M::GFP) Polo variants tagged with GFP were expressed using the Gal4-UAS system. All four constructs were inserted on the second chromosome (attP40, see below) and on the third chromosome (attP154, [29]). Cyclin B::GFP expressing flies were described before [55].

Inscuteable-Gal4 (Insc-Gal4; BDSC #8751) and Worniu-Gal4 (Wor-Gal4; BDSC #56554) allowed the expression of UAS driven fluorescent markers in the neuroblasts; and Actin5C-Gal4 (BDSC #4414) was used for ubiquitous expression in somatic cells. The expression of Polo variants for protein level and rescue assays in Fig 2A and 2B as well as the expression of PoloT182D::GFP for ploidy analysis (Fig 5E) were performed using the Actin5C-Gal4 driver. The expression of mCherry::Jupiter and PoloT182D::GFP in ial mutant background were driven by Wor-Gal4. For other experiments (live-imaging, immunofluorescence and transplantation assay), Polo variants and the microtubule marker were expressed under the control of Insc-Gal4.

The following alleles were used in this study and described before: aurA8839 (referred as aurA mutant, [9,40]), mad2p [26], polo1 [56], polo9 and polo10 [57], ial1689, ial35.33 and ial2A43 [36]. The allelic combination polo9/polo10 (referred as polo mutant) corresponds to a strong polo hypomorph mutant and the flies do not reach the pupal stage [57]. The allelic combinations polo1/polo9 and polo1/polo10 mutant flies are viable and correspond to weak polo hypomorphic mutants. The phenotype of Ial/Aurora B loss-of-function was assessed during the larval stage using two heteroallelic combinations: ial35.33/ial1689 and ial2A43/ial1689.

Flies were maintained and crossed under standard conditions at 25°C.

Generation of transgenes

The constructs containing the coding sequence of Polo variants (WT, T182A, T182D and K54M) C-terminally tagged with GFP were cloned into the plasmid pUAS-K10-attB [29] and were injected in embryos for targeted insertion on the attP40 site located on second chromosome (BestGene Inc.).

Immunohistochemistry and antibodies

Third instar larval brains (120 to 144 h after egg lying depending on overall growth delay) were dissected in Schneider medium supplemented with 10% FCS and fixed in Testis Buffer (183 mM KCl, 47 mM NaCl, 10 mM Tris, and 1 mM EDTA, pH 6.8) containing 10% formaldehyde and 0.01% Triton X-100 at 25°C for 20 minutes, as described in a previous study [7].

Primary antibodies: monoclonal anti-α-tubulin DM1A (mouse, 1:500, Sigma T6199), anti-PKCζ (C-20) (rabbit, 1:250, Santa Cruz sc-216), anti-Miranda (rat, 1:200, Abcam 197788), polyclonal anti-phosphorylated Ser10 of Histone H3 (rabbit, 1:500, Millipore 06–570), anti-Deadpan (rat, 1:200, Abcam 195172), anti-Cnn (rabbit, 1:500, [58]) and monoclonal anti-phospho-Plk1T210 (mouse, 1:500, Abcam ab39068).

Secondary antibodies: anti-rat, anti-mouse and anti-rabbit conjugated to 488, 568, 647 Alexa-Fluor (1:500 to 1:1000, Life Technologies).

Images were acquired on a Leica SP5 confocal microscope using 40X (1.25 N.A.) and 63X (1.40 N.A.) objectives, controlled with Leica LAS software and analyzed on Fiji or Imaris.

Western blotting and antibodies

Two to three brains were dissected, resuspended in Laemmli Buffer and loaded on a 4–15% Mini-PROTEAN TGX Precast Protein Gel (BioRad). After migration, proteins are transferred on a nitrocellulose membrane using a Trans-Blot Turbo (BioRad). Membranes were washed with PBS+0.1% Tween20 (PBST) and blocked with PBST+5 to 10% powder milk. The membranes were then incubated in the following primary antibodies, diluted in TBST+2.5 to 5% powder milk: Rabbit polyclonal anti-Actin (I-19, Santa Cruz sc-1616-R; 1/4000), anti-Mad2 (Gift from David Sharp; 1/500), mouse monoclonal anti-Polo MA294 (Gift from David Glover; 1/100). Anti-mouse and anti-rabbit secondary antibodies were purchased from Jackson ImmunoResearch. Western blots were revealed with SuperSignal West Dura or Femto (ThermoFisher).

Live cell imaging

Third instar larval brains (120 to 144h after egg lying depending on overall growth delay) were dissected in Schneider medium containing 10% FCS and transferred to 50 μL wells (Ibidi, μ-Slide Angiogenesis) for live imaging. Mutant and control brains were imaged in parallel at 25°C. Z-series (thickness of 20 μm with 1 μm spacing) were acquired with a temporal resolution of 30 to 90 s for 1 to 2.5 hours. Alternatively, samples were mounted on a stainless-steel slide, between coverslip and mineral oil as described in a previous study [59].

Images were acquired with a spinning disk system consisting of a DMi8 microscope (Leica) equipped with a 63X (1.4 N.A.) oil objective, a CSU-X1 spinning disk unit (Yokogawa) and an Evolve EMCCD camera (Photometrics). The microscope was controlled by the Inscoper Imaging Suite and the dedicated software (Inscoper). Alternatively, a CSU-X1 spinning-disk unit mounted on an inverted microscope (Elipse Ti; Nikon) equipped with a 60X (1.4 N.A.) oil objective, a sCMOS ORCA Flash 4.0 (Hamamatsu) and controlled by MetaMorph; was also used for some experiments. Images were processed with Fiji or Imaris softwares.

Image analyses

Time in mitosis

The time in mitosis was determined as described in [31,59,60]. Briefly, the mitotic entry point was determined when an increase of the mCherry::tubulin signal was detected in the nuclear region, reflecting dismantlement and permeabilization of the nuclear envelope to tubulin. Anaphase onset was determined as the first spindle elongation time point.

Note that only the cells undergoing complete mitosis within the span of the experiments were scored. For aurA;ial double mutant (S3B and S3C Fig) displaying the most severe phenotype, the cells could not complete mitosis throughout the experiment (2.5 h) and the time in mitosis could not be measured.

Cyclin B::GFP degradation

Cyclin B::GFP degradation kinetics were analyzed in individual NSCs undergoing complete mitosis within the span of the experiments. GFP total fluorescence intensities were quantified for the whole cell. The signal was adjusted for background and for bleaching relative to the signal of a non-mitotic cell. In the graphs, signal levels for the whole cell are displayed as normalized signals relative to the maximal intensity measured for the cell as described in previous studies [2,26,61].

Spindle orientation

Spindle orientation on fixed tissue was measured on metaphase cells using the angle tool of Fiji or alternatively using the “spot” tool of Imaris. Briefly, two spots were placed in the center of the apical aPKC and basal Miranda crescents to determine the polarity axis; two spots positioned at the spindle poles determined the mitotic spindle axis. For aurA mutant that did not exhibit an apical aPKC crescent, the polarity axis was determined by a straight line between the center of the Miranda crescent and a second spot at the opposite cortex. The 3D coordinates of the spots were used to calculate polarity and spindle axes vectors and the angle between them as described in [62].

Cnn intensity

Total Cnn total intensity (“Sum slices”) was measured on spindle poles of metaphase NSCs using Fiji software. The spindle poles were defined thanks to Cnn and tubulin staining. For each cell, 1 measurement in the cytoplasm was used and subtracted from the spindle pole intensity values.

Phospho-Plk1 intensity

Z-projections of images restricted to the metaphase plates were made using Fiji (“Sum slices”). Using phospho-Histone H3 staining, metaphase plate shapes were drawn on Fiji (orange lines in S3D Fig) and phospho-Plk1 total signal intensities were measured. Raw intensities were normalized by the volume of measurement.

Ploidy analysis in brains

Third instar larval brains were dissected in PBS, incubated for 8 minutes in 0.5% sodium citrate solution, fixed in acetic acid (45% for 45 seconds and 60% for 2 minutes), squashed between slide and coverslip and flash-frozen in liquid nitrogen [2]. After coverslip flip off, the squashed cells on the slide were washed in PBS and mounted in ProlonGold supplemented with DAPI. Images were acquired using a Leica DMRXA2 microscope equipped a 63X (1.32 N.A.) objective, a CoolSnap HQ2 camera and controlled by MetaMorph. Images were processed with Fiji software.

Tumor transplantation assay

The protocol to assess proliferation ability of brain tissues was originally set up in the lab of Cayetano Gonzalez [41]. Briefly, a central brain fragment (expressing a fluorescent probe) was transplanted in the abdomen of a live wild-type adult female fly and the growth of the transplant was monitored over time. Control or mutant third instar larval brains, expressing either His2Av::GFP or UAS-Cherry::Tubulin under the control of Insc-Gal4 were dissected in sterile PBS (Sigma). One brain lobe was transplanted in the abdomen of a wild-type adult fly using a pulled capillary with a beveled tip (around 150 μm diameter) adjusted to a microinjection system (IM-9B; Narishige). After transplantation, host flies were maintained at 18°C overnight and transferred at 25°C for a month. Tumor growth was monitored every one or two days upon 30 days for the appearance of a mCherry or GFP signal in the abdomen. For aurA and strong polo mutants, transplant growth was assessed over a 15-days period because these tumors were particularly aggressive and killed the host flies before 30 days. The neuroblast-specific Insc-Gal4 was used to assay the effect of PoloT182D::GFP variant for tumor growth.

Statistical analyses

Sample size and statistical test used for each analysis are found in the corresponding figure legends. Statistical analyses were performed using the Prism software (Version 7, GraphPad). Three tests were used according to the data. To compare ranks between two unpaired samples with variable variances and non-Gaussian distributions, a nonparametric Mann-Whitney test was used. To compare two unpaired samples with Gaussian distribution, a nonparametric t test was used complemented with a Welch correction if standard deviations were unequal (F test). The comparisons of proportions were assessed by a two-sided Fisher’s exact test with a confidence index of 95%. Significance are displayed on the figure: ns: p>0.05; *: p<0.05; **: p<0.01; ***: p<0.001; ****: p<0.0001. Numerical data (mean, SD and n) related to all the figures are available in S1 Data.

Supporting information

S1 Fig. Cyclin B degradation kinetics in polo mutant NSCs.

A) Time-lapse imaging of mitosis in polo mutants in the absence or presence of Mad2. Selected image series of dividing NSCs of the indicated genotypes expressing mCherry::Tubulin (purple in the top panels and in the middle monochrome panels), and CyclinB::GFP (green and lower monochrome panels). The white dashed line outlines the dividing NSCs. Scale bar: 5 μm. Time is min:s (t = 00:00 is NEBD). B) Cyclin B::GFP degradation profiles in WT, in polo9/polo10 NSCs, and in polo9/polo10, mad2P double-mutant NSCs. C) Quantification of the time in mitosis (min) in NSCs for the indicated genotypes. D) Quantification of the time (min) required for 50% of Cyclin B::GFP degradation for the indicated genotypes. Mann-Whitney unpaired tests: ns: p>0.05; *: p<0.05; ****: p<0.0001.

(TIF)

S2 Fig. Localization of GFP-tagged Polo variants during NSC division.

A) Time-lapse imaging of cell division in NSCs expressing the indicated Polo variants and mCherry::Tubulin. The white dashed line outlines the NSCs. Scale bar: 5 μm. Time is min:s (t = 00:00 is NEBD). B) Summary table of Polo variants localization patterns along cell cycle stages. The symbols “-”, “+/-”, “+”and “++” reflect absence, variable localization, moderate localization and strong enrichment, respectively.

(TIF)

S3 Fig. Analysis Polo activation in different mutant backgrounds.

A) Quantification of the time in mitosis for the indicated genotypes. B) Time-lapse imaging of dividing NSCs for control and ial;aurA double mutant NSCs expressing RFP::Tubulin. The white dashed lines outline the dividing NSCs. Scale bar: 5 μm. Time is h:min:s (t = 0:00:00 is the beginning of the experiment). C) Quantification of the time in mitosis of NSCs of the indicated genotypes. The ial;aurA double mutant NSCs displayed a severe mitotic delay that could not be quantified since the vast majority did not complete mitosis during the duration of the experiment (2.5 hours). Mann-Whitney unpaired test: ns: p>0.05; ****: p<0.0001. D) Representative images of metaphase NSCs of the indicated genotypes stained for phospho-Plk1 (white in the merge), aPKC and Phospho-Histone H3 (magenta in the merge) and tubulin (green in the merge). The orange shapes in the right column outline the metaphase plates, according to the Phospho-Histone H3-labeled metaphase plate, in which phospho-Plk1 signal was measured. Scale bar: 5 μm. E) Quantification of phospho-Plk1 signal for the indicated genotypes, normalized by the area of measurement. Unpaired t-test: ns: p>0.05; **: p<0.01; ***: p<0.001; ****: p<0.0001.

(TIF)

S4 Fig. Polo activation restores centrosome maturation in aurA mutant NSCs.

A) Representative images of metaphase NSCs of the indicated genotypes stained for Miranda (magenta in the merge), aPKC and Cnn (green in the merge) and tubulin (white in the merge). The yellow arrowheads in the bottom line highlight the Cnn-labeled spindle poles. Scale bar: 5 μm. B) Quantification of normalized Cnn intensity at spindle poles for the indicated genotypes. Mann-Whitney unpaired tests: ns: non-significant, *: p<0.05; **: p<0.01; ****: p<0.0001.

(TIF)

S1 Data. Numerical data corresponding to Figs 1, 2, 3, 4, 5, S1, S3 and S4.

(XLSX)

S1 Movie

Polo variants expressed in polo mutant NSCs larval NSCs of the indicated genotypes (from left to right: wild-type, polo mutant, polo mutant expressing PoloWT:: GFP and polo mutant expressing PoloT182D::GFP) expressing mCherry::Tubulin under the control of Insc-Gal4. Microtubule marker and Polo variants are shown in magenta and green respectively. PoloWT is able to restore a normal mitotic timing in polo mutant while PoloT182D decreases the mitotic delay by more than half. Scale bar: 5 μm. Time is min:s. « 00:00 » corresponds to NEBD.

(AVI)

S2 Movie. Constitutively active Polo reduces the mitotic delay of aurA mutant NSCs.

Larval NSCs of the indicated genotypes (from left to right: wild-type, aurA mutant and aurA mutant expressing PoloT182D::GFP) expressing mCherry::Tubulin under the control of Insc-Gal4. Microtubule marker and Polo variants are shown in magenta and green respectively. PoloT182D is able to reduce the time in mitosis of aurA mutant NSCs. Scale bar: 5 μm. Time is min:s. « 00:00 » corresponds to NEBD.

(AVI)

Acknowledgments

We thank members of the “Cytoskeleton and Cell Proliferation” lab, Roland Le Borgne and Damien Coudreuse for helpful discussions. We are grateful to Renata Basto for advices on tumor growth assays, Anne Royou, Jordan Raff, Clemens Cabernard, David Sharp, Timothy Megraw, Juliette Mathieu and Jean-René Huynh for antibodies, flies and plasmids. We also acknowledge Stéphanie Dutertre and Xavier Pinson for their help using the microscopes of the Microscopy Rennes imaging center facility (MRic).

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

Fondation pour la Recherche Médicale (FRM):DEQ20170336742 to RG. Ligue Contre le Cancer to RG. Canadian Institutes of Health Research to VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Daley GQ. Stem cells and the evolving notion of cellular identity. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2015. Oct 19;370(1680):20140376. doi: 10.1098/rstb.2014.0376 . Pubmed Central PMCID: PMC4634003. Epub 2015/09/30. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Caous R, Pascal A, Rome P, Richard-Parpaillon L, Karess R, Giet R. Spindle assembly checkpoint inactivation fails to suppress neuroblast tumour formation in aurA mutant Drosophila. Nat Commun. 2015;6:8879. doi: 10.1038/ncomms9879 . Pubmed Central PMCID: 4660220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gogendeau D, Siudeja K, Gambarotto D, Pennetier C, Bardin AJ, Basto R. Aneuploidy causes premature differentiation of neural and intestinal stem cells. Nat Commun. 2015;6:8894. doi: 10.1038/ncomms9894 . Pubmed Central PMCID: 4660207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Homem CC, Knoblich JA. Drosophila neuroblasts: a model for stem cell biology. Development. 2012. Dec 1;139(23):4297–310. doi: 10.1242/dev.080515 . [DOI] [PubMed] [Google Scholar]
  • 5.Januschke J, Gonzalez C. Drosophila asymmetric division, polarity and cancer. Oncogene. 2008. Nov 24;27(55):6994–7002. doi: 10.1038/onc.2008.349 . [DOI] [PubMed] [Google Scholar]
  • 6.Ramdas Nair A, Singh P, Salvador Garcia D, Rodriguez-Crespo D, Egger B, Cabernard C. The Microcephaly-Associated Protein Wdr62/CG7337 Is Required to Maintain Centrosome Asymmetry in Drosophila Neuroblasts. Cell reports. 2016. Feb 9;14(5):1100–13. doi: 10.1016/j.celrep.2015.12.097 . Epub 2016/01/26. eng. [DOI] [PubMed] [Google Scholar]
  • 7.Gallaud E, Pham T, Cabernard C. Drosophila melanogaster Neuroblasts: A Model for Asymmetric Stem Cell Divisions. Results and problems in cell differentiation. 2017;61:183–210. doi: 10.1007/978-3-319-53150-2_8 . [DOI] [PubMed] [Google Scholar]
  • 8.Johnston CA, Hirono K, Prehoda KE, Doe CQ. Identification of an Aurora-A/PinsLINKER/Dlg spindle orientation pathway using induced cell polarity in S2 cells. Cell. 2009. Sep 18;138(6):1150–63. doi: 10.1016/j.cell.2009.07.041 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lee CY, Andersen RO, Cabernard C, Manning L, Tran KD, Lanskey MJ, et al. Drosophila Aurora-A kinase inhibits neuroblast self-renewal by regulating aPKC/Numb cortical polarity and spindle orientation. Genes Dev. 2006. Dec 15;20(24):3464–74. doi: 10.1101/gad.1489406 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wang E, Ballister ER, Lampson MA. Aurora B dynamics at centromeres create a diffusion-based phosphorylation gradient. J Cell Biol. 2011. Aug 22;194(4):539–49. doi: 10.1083/jcb.201103044 . Pubmed Central PMCID: 3160582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Wirtz-Peitz F, Nishimura T, Knoblich JA. Linking cell cycle to asymmetric division: Aurora-A phosphorylates the Par complex to regulate Numb localization. Cell. 2008. Oct 3;135(1):161–73. doi: 10.1016/j.cell.2008.07.049 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wang H, Ouyang Y, Somers WG, Chia W, Lu B. Polo inhibits progenitor self-renewal and regulates Numb asymmetry by phosphorylating Pon. Nature. 2007. Sep 6;449(7158):96–100. doi: 10.1038/nature06056 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Corbett KD. Molecular Mechanisms of Spindle Assembly Checkpoint Activation and Silencing. Progress in molecular and subcellular biology. 2017;56:429–55. doi: 10.1007/978-3-319-58592-5_18 . Epub 2017/08/26. eng. [DOI] [PubMed] [Google Scholar]
  • 14.Dominguez-Brauer C, Thu KL, Mason JM, Blaser H, Bray MR, Mak TW. Targeting Mitosis in Cancer: Emerging Strategies. Mol Cell. 2015. Nov 19;60(4):524–36. doi: 10.1016/j.molcel.2015.11.006 . [DOI] [PubMed] [Google Scholar]
  • 15.Janssen A, Kops GJ, Medema RH. Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proc Natl Acad Sci U S A. 2009. Nov 10;106(45):19108–13. doi: 10.1073/pnas.0904343106 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Silk AD, Zasadil LM, Holland AJ, Vitre B, Cleveland DW, Weaver BA. Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors. Proc Natl Acad Sci U S A. 2013. Oct 29;110(44):E4134–41. doi: 10.1073/pnas.1317042110 . Pubmed Central PMCID: 3816416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Poulton JS, Cuningham JC, Peifer M. Centrosome and spindle assembly checkpoint loss leads to neural apoptosis and reduced brain size. J Cell Biol. 2017. May 1;216(5):1255–65. doi: 10.1083/jcb.201607022 . Pubmed Central PMCID: PMC5412557. Epub 2017/03/30. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Giet R, McLean D, Descamps S, Lee MJ, Raff JW, Prigent C, et al. Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules. J Cell Biol. 2002. Feb 4;156(3):437–51. doi: 10.1083/jcb.200108135 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Glover DM, Leibowitz MH, McLean DA, Parry H. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell. 1995. Apr 7;81(1):95–105. doi: 10.1016/0092-8674(95)90374-7 . [DOI] [PubMed] [Google Scholar]
  • 20.Tavernier N, Thomas Y, Vigneron S, Maisonneuve P, Orlicky S, Mader P, et al. Bora phosphorylation substitutes in trans for T-loop phosphorylation in Aurora A to promote mitotic entry. Nat Commun. 2021. Mar 26;12(1):1899. doi: 10.1038/s41467-021-21922-w . Pubmed Central PMCID: PMC7997955. Epub 2021/03/28. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Vigneron S, Sundermann L, Labbé JC, Pintard L, Radulescu O, Castro A, et al. Cyclin A-cdk1-Dependent Phosphorylation of Bora Is the Triggering Factor Promoting Mitotic Entry. Dev Cell. 2018. Jun 4;45(5):637–50 e7. doi: 10.1016/j.devcel.2018.05.005 . Epub 2018/06/06. eng. [DOI] [PubMed] [Google Scholar]
  • 22.Joukov V, Walter JC, De Nicolo A. The Cep192-organized aurora A-Plk1 cascade is essential for centrosome cycle and bipolar spindle assembly. Mol Cell. 2014. Aug 21;55(4):578–91. doi: 10.1016/j.molcel.2014.06.016 . Pubmed Central PMCID: 4245277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kachaner D, Pinson X, El Kadhi KB, Normandin K, Talje L, Lavoie H, et al. Interdomain allosteric regulation of Polo kinase by Aurora B and Map205 is required for cytokinesis. J Cell Biol. 2014. Oct 27;207(2):201–11. doi: 10.1083/jcb.201408081 . Pubmed Central PMCID: 4210448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Macurek L, Lindqvist A, Lim D, Lampson MA, Klompmaker R, Freire R, et al. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature. 2008. Sep 4;455(7209):119–23. doi: 10.1038/nature07185 . [DOI] [PubMed] [Google Scholar]
  • 25.Seki A, Coppinger JA, Jang CY, Yates JR, Fang G. Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science. 2008. Jun 20;320(5883):1655–8. doi: 10.1126/science.1157425 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Buffin E, Emre D, Karess RE. Flies without a spindle checkpoint. Nat Cell Biol. 2007. May;9(5):565–72. doi: 10.1038/ncb1570 . [DOI] [PubMed] [Google Scholar]
  • 27.Joukov V, De Nicolo A. Aurora-PLK1 cascades as key signaling modules in the regulation of mitosis. Sci Signal. 2018. Aug 14;11(543). doi: 10.1126/scisignal.aar4195 . [DOI] [PubMed] [Google Scholar]
  • 28.Bruinsma W, Macurek L, Freire R, Lindqvist A, Medema RH. Bora and Aurora-A continue to activate Plk1 in mitosis. J Cell Sci. 2014. Feb 15;127(Pt 4):801–11. doi: 10.1242/jcs.137216 . [DOI] [PubMed] [Google Scholar]
  • 29.Kachaner D, Garrido D, Mehsen H, Normandin K, Lavoie H, Archambault V. Coupling of Polo kinase activation to nuclear localization by a bifunctional NLS is required during mitotic entry. Nat Commun. 2017. Nov 22;8(1):1701. doi: 10.1038/s41467-017-01876-8 . Pubmed Central PMCID: 5700101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hanisch A, Wehner A, Nigg EA, Silljé HH. Different Plk1 functions show distinct dependencies on Polo-Box domain-mediated targeting. Mol Biol Cell. 2006. Jan;17(1):448–59. doi: 10.1091/mbc.e05-08-0801 . Pubmed Central PMCID: PMC1345681. Epub 2005/11/04. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Barbosa J, Martins T, Bange T, Tao L, Conde C, Sunkel C. Polo regulates Spindly to prevent premature stabilization of kinetochore-microtubule attachments. EMBO J. 2020. Jan 15;39(2):e100789. doi: 10.15252/embj.2018100789 . Pubmed Central PMCID: 6960449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Beck J, Maerki S, Posch M, Metzger T, Persaud A, Scheel H, et al. Ubiquitylation-dependent localization of PLK1 in mitosis. Nat Cell Biol. 2013. Apr;15(4):430–9. doi: 10.1038/ncb2695 . Pubmed Central PMCID: PMC7116173. Epub 2013/03/05. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Paschal CR, Maciejowski J, Jallepalli PV. A stringent requirement for Plk1 T210 phosphorylation during K-fiber assembly and chromosome congression. Chromosoma. 2012. Dec;121(6):565–72. doi: 10.1007/s00412-012-0375-8 . Pubmed Central PMCID: 3519967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Liu D, Davydenko O, Lampson MA. Polo-like kinase-1 regulates kinetochore-microtubule dynamics and spindle checkpoint silencing. J Cell Biol. 2012. Aug 20;198(4):491–9. doi: 10.1083/jcb.201205090 . Pubmed Central PMCID: 3514039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Carmena M, Pinson X, Platani M, Salloum Z, Xu Z, Clark A, et al. The chromosomal passenger complex activates Polo kinase at centromeres. PLoS Biol. 2012. Jan;10(1):e1001250. doi: 10.1371/journal.pbio.1001250 . Pubmed Central PMCID: 3265468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Mathieu J, Cauvin C, Moch C, Radford SJ, Sampaio P, Perdigoto CN, et al. Aurora B and cyclin B have opposite effects on the timing of cytokinesis abscission in Drosophila germ cells and in vertebrate somatic cells. Dev Cell. 2013. Aug 12;26(3):250–65. doi: 10.1016/j.devcel.2013.07.005 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Magnaghi-Jaulin L, Eot-Houllier G, Gallaud E, Giet R. Aurora A Protein Kinase: To the Centrosome and Beyond. Biomolecules. 2019. Jan 15;9(1). doi: 10.3390/biom9010028 . Pubmed Central PMCID: PMC6359016. Epub 2019/01/18. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Conduit PT, Feng Z, Richens JH, Baumbach J, Wainman A, Bakshi SD, et al. The centrosome-specific phosphorylation of Cnn by Polo/Plk1 drives Cnn scaffold assembly and centrosome maturation. Dev Cell. 2014. Mar 31;28(6):659–69. doi: 10.1016/j.devcel.2014.02.013 . Pubmed Central PMCID: 3988887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Castellanos E, Dominguez P, Gonzalez C. Centrosome dysfunction in Drosophila neural stem cells causes tumors that are not due to genome instability. Curr Biol. 2008. Aug 26;18(16):1209–14. doi: 10.1016/j.cub.2008.07.029 . [DOI] [PubMed] [Google Scholar]
  • 40.Wang H, Cai Y, Chia W, Yang X. Drosophila homologs of mammalian TNF/TNFR-related molecules regulate segregation of Miranda/Prospero in neuroblasts. EMBO J. 2006. Dec 13;25(24):5783–93. doi: 10.1038/sj.emboj.7601461 . Pubmed Central PMCID: 1698905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Caussinus E, Gonzalez C. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat Genet. 2005. Oct;37(10):1125–9. doi: 10.1038/ng1632 . [DOI] [PubMed] [Google Scholar]
  • 42.Wang H, Somers GW, Bashirullah A, Heberlein U, Yu F, Chia W. Aurora-A acts as a tumor suppressor and regulates self-renewal of Drosophila neuroblasts. Genes Dev. 2006. Dec 15;20(24):3453–63. doi: 10.1101/gad.1487506 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Jia L, Li B, Yu H. The Bub1-Plk1 kinase complex promotes spindle checkpoint signalling through Cdc20 phosphorylation. Nat Commun. 2016. Feb 25;7:10818. doi: 10.1038/ncomms10818 . Pubmed Central PMCID: PMC4773433. Epub 2016/02/26. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Qiao R, Weissmann F, Yamaguchi M, Brown NG, VanderLinden R, Imre R, et al. Mechanism of APC/CCDC20 activation by mitotic phosphorylation. Proc Natl Acad Sci U S A. 2016. May 10;113(19):E2570–8. doi: 10.1073/pnas.1604929113 . Pubmed Central PMCID: 4868491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Zhang S, Chang L, Alfieri C, Zhang Z, Yang J, Maslen S, et al. Molecular mechanism of APC/C activation by mitotic phosphorylation. Nature. 2016. Apr 27;533(7602):260–4. doi: 10.1038/nature17973 . Pubmed Central PMCID: 4878669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Gonzalez C. Spindle orientation, asymmetric division and tumour suppression in Drosophila stem cells. Nat Rev Genet. 2007. Jun;8(6):462–72. doi: 10.1038/nrg2103 . [DOI] [PubMed] [Google Scholar]
  • 47.Reich JD, Hubatsch L, Illukkumbura R, Peglion F, Bland T, Hirani N, et al. Regulated Activation of the PAR Polarity Network Ensures a Timely and Specific Response to Spatial Cues. Curr Biol. 2019. Jun 17;29(12):1911–23 e5. doi: 10.1016/j.cub.2019.04.058 . Pubmed Central PMCID: PMC6584329. Epub 2019/06/04. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Noatynska A, Panbianco C, Gotta M. SPAT-1/Bora acts with Polo-like kinase 1 to regulate PAR polarity and cell cycle progression. Development. 2010. Oct;137(19):3315–25. doi: 10.1242/dev.055293 . Epub 2010/09/09. eng. [DOI] [PubMed] [Google Scholar]
  • 49.Dickinson DJ, Schwager F, Pintard L, Gotta M, Goldstein B. A Single-Cell Biochemistry Approach Reveals PAR Complex Dynamics during Cell Polarization. Dev Cell. 2017. Aug 21;42(4):416–34 e11. doi: 10.1016/j.devcel.2017.07.024 . Pubmed Central PMCID: PMC5575849. Epub 2017/08/23. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Zhao P, Teng X, Tantirimudalige SN, Nishikawa M, Wohland T, Toyama Y, et al. Aurora-A Breaks Symmetry in Contractile Actomyosin Networks Independently of Its Role in Centrosome Maturation. Dev Cell. 2019. Mar 11;48(5):631–45 e6. doi: 10.1016/j.devcel.2019.02.012 . Epub 2019/03/13. eng. [DOI] [PubMed] [Google Scholar]
  • 51.Cabernard C, Prehoda KE, Doe CQ. A spindle-independent cleavage furrow positioning pathway. Nature. 2010. Sep 2;467(7311):91–4. doi: 10.1038/nature09334 . Pubmed Central PMCID: 4028831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hutterer A, Berdnik D, Wirtz-Peitz F, Zigman M, Schleiffer A, Knoblich JA. Mitotic activation of the kinase Aurora-A requires its binding partner Bora. Dev Cell. 2006. Aug;11(2):147–57. doi: 10.1016/j.devcel.2006.06.002 . [DOI] [PubMed] [Google Scholar]
  • 53.Macurek L, Lindqvist A, Medema RH. Aurora-A and hBora join the game of Polo. Cancer Res. 2009. Jun 1;69(11):4555–8. doi: 10.1158/0008-5472.CAN-09-0142 . [DOI] [PubMed] [Google Scholar]
  • 54.Clarkson M, Saint R. A His2AvDGFP fusion gene complements a lethal His2AvD mutant allele and provides an in vivo marker for Drosophila chromosome behavior. DNA and cell biology. 1999. Jun;18(6):457–62. doi: 10.1089/104454999315178 . Epub 1999/07/02. eng. [DOI] [PubMed] [Google Scholar]
  • 55.Huang J, Raff JW. The disappearance of cyclin B at the end of mitosis is regulated spatially in Drosophila cells. EMBO J. 1999. Apr 15;18(8):2184–95. doi: 10.1093/emboj/18.8.2184 . Pubmed Central PMCID: 1171302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sunkel CE, Glover DM. polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J Cell Sci. 1988. Jan;89 (Pt 1):25–38. doi: 10.1242/jcs.89.1.25 . [DOI] [PubMed] [Google Scholar]
  • 57.Donaldson MM, Tavares AA, Ohkura H, Deak P, Glover DM. Metaphase arrest with centromere separation in polo mutants of Drosophila. J Cell Biol. 2001. May 14;153(4):663–76. doi: 10.1083/jcb.153.4.663 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Megraw TL, Li K, Kao LR, Kaufman TC. The centrosomin protein is required for centrosome assembly and function during cleavage in Drosophila. Development. 1999. Jul;126(13):2829–39. doi: 10.1242/dev.126.13.2829 . Epub 1999/06/08. eng. [DOI] [PubMed] [Google Scholar]
  • 59.Gallaud E, Caous R, Pascal A, Bazile F, Gagne JP, Huet S, et al. Ensconsin/Map7 promotes microtubule growth and centrosome separation in Drosophila neural stem cells. J Cell Biol. 2014. Mar 31;204(7):1111–21. doi: 10.1083/jcb.201311094 . Pubmed Central PMCID: 3971751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Métivier M, Gallaud E, Thomas A, Pascal A, J-P. G, Poirier GG, et al. Drosophila dTBCE recruits tubulin around chromatin to promote mitotic spindle assembly. Current Biology. 2020. doi: 10.1016/j.cub.2020.11.009 [DOI] [PubMed] [Google Scholar]
  • 61.Clute P, Pines J. Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol. 1999. Jun;1(2):82–7. doi: 10.1038/10049 . [DOI] [PubMed] [Google Scholar]
  • 62.Loyer N, Januschke J. The last-born daughter cell contributes to division orientation of Drosophila larval neuroblasts. Nat Commun. 2018. Sep 14;9(1):3745. doi: 10.1038/s41467-018-06276-0 . Pubmed Central PMCID: PMC6138640. Epub 2018/09/16. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Gregory P Copenhaver, Yan Song

13 Sep 2021

Dear Dr Giet,

Thank you very much for submitting your Research Article entitled The spindle assembly checkpoint and the spatial activation of Polo kinase determine the duration of cell division and prevent neural stem cells tumor formation' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers at Review Commons. The reviewers all considered your paper to be potentially interesting, but Reviewer #1 and #2 raised some substantial concerns about the current manuscript. Main questions need to be resolved include whether the WT and the putative phospho-mutant forms (T182A) of Polo rescue AurA mutant phenotypes and whether measurement of mitotic duration using alternative approach(s) other than mCherry-Tubulin yield similar results. Here, a Cyclin B-GFP reporter or fly FUCCI can be used as alternative approaches to measure mitotic duration. Based on the reviews and your point-by-point response to the reviewers’ comments, we will not be able to accept the current version of the manuscript, but we would be happy to consider a revised version.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Yan Song, Ph.D.

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Decision Letter 1

Gregory P Copenhaver, Yan Song

28 Feb 2022

Dear Dr Giet,

Thank you very much for submitting your revised manuscript to PLOS Genetics. I am pleased to let you know that, based on your revisions and the reviewer comments below, your manuscript can now be accepted in principle at PLOS Genetics. As you will see there are still some minor points raised by Reviewer #2 with regards to citation and typos. We will be able to formally accept your manuscript once you have uploaded final files that fully address these specific points made by Reviewer #2.

In addition we ask that you:

1) Provide a list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 1-2 weeks. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

 

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these minor revisions. We look forward to hearing from you.

Yours sincerely,

Yan Song, Ph.D.

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have adequately addressed comments from previous reviewers. The manuscript is now recommended for publication in PLoS Genetics.

Reviewer #2: The authors have added quantification of WT and T182A alleles in Figures 5 and S4 and have substantiated their conclusion that Cyclin B degradation is slowed in polo mutants. These additions have strengthened the manuscript and I am supportive of publication. Below I list 2 minor typos that should be corrected.

1) The section describing the Figure 2E should include an explanation of the T182A and K54M phenotypes, and should reference the papers showing attributing this to dominant negative effects.

2) Figure S1C. Y axis label should read “mitosis”

Decision Letter 2

Gregory P Copenhaver, Yan Song

14 Mar 2022

Dear Dr Giet,

We are pleased to inform you that your manuscript entitled "The spindle assembly checkpoint and the spatial activation of Polo kinase determine the duration of cell division and prevent tumor formation" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Yan Song, Ph.D.

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-21-01184R2

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory P Copenhaver, Yan Song

30 Mar 2022

PGENETICS-D-21-01184R2

The spindle assembly checkpoint and the spatial activation of Polo kinase determine the duration of cell division and prevent tumor formation

Dear Dr Giet,

We are pleased to inform you that your manuscript entitled "The spindle assembly checkpoint and the spatial activation of Polo kinase determine the duration of cell division and prevent tumor formation" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofia Freund

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Cyclin B degradation kinetics in polo mutant NSCs.

    A) Time-lapse imaging of mitosis in polo mutants in the absence or presence of Mad2. Selected image series of dividing NSCs of the indicated genotypes expressing mCherry::Tubulin (purple in the top panels and in the middle monochrome panels), and CyclinB::GFP (green and lower monochrome panels). The white dashed line outlines the dividing NSCs. Scale bar: 5 μm. Time is min:s (t = 00:00 is NEBD). B) Cyclin B::GFP degradation profiles in WT, in polo9/polo10 NSCs, and in polo9/polo10, mad2P double-mutant NSCs. C) Quantification of the time in mitosis (min) in NSCs for the indicated genotypes. D) Quantification of the time (min) required for 50% of Cyclin B::GFP degradation for the indicated genotypes. Mann-Whitney unpaired tests: ns: p>0.05; *: p<0.05; ****: p<0.0001.

    (TIF)

    S2 Fig. Localization of GFP-tagged Polo variants during NSC division.

    A) Time-lapse imaging of cell division in NSCs expressing the indicated Polo variants and mCherry::Tubulin. The white dashed line outlines the NSCs. Scale bar: 5 μm. Time is min:s (t = 00:00 is NEBD). B) Summary table of Polo variants localization patterns along cell cycle stages. The symbols “-”, “+/-”, “+”and “++” reflect absence, variable localization, moderate localization and strong enrichment, respectively.

    (TIF)

    S3 Fig. Analysis Polo activation in different mutant backgrounds.

    A) Quantification of the time in mitosis for the indicated genotypes. B) Time-lapse imaging of dividing NSCs for control and ial;aurA double mutant NSCs expressing RFP::Tubulin. The white dashed lines outline the dividing NSCs. Scale bar: 5 μm. Time is h:min:s (t = 0:00:00 is the beginning of the experiment). C) Quantification of the time in mitosis of NSCs of the indicated genotypes. The ial;aurA double mutant NSCs displayed a severe mitotic delay that could not be quantified since the vast majority did not complete mitosis during the duration of the experiment (2.5 hours). Mann-Whitney unpaired test: ns: p>0.05; ****: p<0.0001. D) Representative images of metaphase NSCs of the indicated genotypes stained for phospho-Plk1 (white in the merge), aPKC and Phospho-Histone H3 (magenta in the merge) and tubulin (green in the merge). The orange shapes in the right column outline the metaphase plates, according to the Phospho-Histone H3-labeled metaphase plate, in which phospho-Plk1 signal was measured. Scale bar: 5 μm. E) Quantification of phospho-Plk1 signal for the indicated genotypes, normalized by the area of measurement. Unpaired t-test: ns: p>0.05; **: p<0.01; ***: p<0.001; ****: p<0.0001.

    (TIF)

    S4 Fig. Polo activation restores centrosome maturation in aurA mutant NSCs.

    A) Representative images of metaphase NSCs of the indicated genotypes stained for Miranda (magenta in the merge), aPKC and Cnn (green in the merge) and tubulin (white in the merge). The yellow arrowheads in the bottom line highlight the Cnn-labeled spindle poles. Scale bar: 5 μm. B) Quantification of normalized Cnn intensity at spindle poles for the indicated genotypes. Mann-Whitney unpaired tests: ns: non-significant, *: p<0.05; **: p<0.01; ****: p<0.0001.

    (TIF)

    S1 Data. Numerical data corresponding to Figs 1, 2, 3, 4, 5, S1, S3 and S4.

    (XLSX)

    S1 Movie

    Polo variants expressed in polo mutant NSCs larval NSCs of the indicated genotypes (from left to right: wild-type, polo mutant, polo mutant expressing PoloWT:: GFP and polo mutant expressing PoloT182D::GFP) expressing mCherry::Tubulin under the control of Insc-Gal4. Microtubule marker and Polo variants are shown in magenta and green respectively. PoloWT is able to restore a normal mitotic timing in polo mutant while PoloT182D decreases the mitotic delay by more than half. Scale bar: 5 μm. Time is min:s. « 00:00 » corresponds to NEBD.

    (AVI)

    S2 Movie. Constitutively active Polo reduces the mitotic delay of aurA mutant NSCs.

    Larval NSCs of the indicated genotypes (from left to right: wild-type, aurA mutant and aurA mutant expressing PoloT182D::GFP) expressing mCherry::Tubulin under the control of Insc-Gal4. Microtubule marker and Polo variants are shown in magenta and green respectively. PoloT182D is able to reduce the time in mitosis of aurA mutant NSCs. Scale bar: 5 μm. Time is min:s. « 00:00 » corresponds to NEBD.

    (AVI)

    Attachment

    Submitted filename: 116860_1_rebuttal_2116136_qw6dw3.docx

    Attachment

    Submitted filename: plos genetics response to reviewers_25-02-22_EG.docx

    Attachment

    Submitted filename: plos genetics response to reviewers_25-02-22_EG.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES